Design, synthesis and biological evaluation of novel indole derivatives as potential HDAC/BRD4 dual inhibitors and anti-leukemia agents
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 84, 410-417
Abstract
No abstract availableKeywords
Funding Information
- National Nature Science Foundation of China (81473086)
This publication has 26 references indexed in Scilit:
- Development of 4,5-dihydro-benzodiazepinone derivatives as a new chemical series of BRD4 inhibitorsEuropean Journal of Medicinal Chemistry, 2016
- The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer EffectsClinical Cancer Research, 2016
- Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cellsOncotarget, 2015
- Panobinostat: First Global ApprovalDrugs, 2015
- Belinostat: First Global ApprovalDrugs, 2014
- RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomainProceedings of the National Academy of Sciences, 2013
- Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain LigandsJournal of Medicinal Chemistry, 2013
- Epigenetic protein families: a new frontier for drug discoveryNature Reviews Drug Discovery, 2012
- RomidepsinDrugs, 2011
- Acetylation: a regulatory modification to rival phosphorylation?The EMBO Journal, 2000